Article
Draft For Soliciting Opinions On The Anti-Monopoly Guidelines In The Pharmaceutical Sector Released: Key Highlights For Pharmaceutical Companies
On August 9, 2024, the State Administration for Market Regulation (SAMR) released the Anti-Monopoly Guidelines for the Pharmaceutical Sector (Draft for Public Comment) (hereinafter referred to as the Pharmaceutical Anti-Monopoly Guidelines or the Guidelines) to solicit opinions from the public.
China
Anti-trust